Cardiology question regarding Journey Brown

[hirshber]

I was under the impression that Michigan does routine echocardiograms on all incoming freshman football and basketball players. I thought this was routine for all universities. I am not sure if it is done annually, but I am quite confident it is done on all freshmen at least and this is how Mo Hurst’s condition was identified early in his career but he was still allowed to play. I believe the cardiology fellows do it. I also had a friend who is a cardiologist for the Golden State Warriors and Oakland Raiders, and I believe the Warriors had echocardiogram done annually and the NFL gets them on all first-year players (I may have this reversed).

so, this is my question. Assuming they do routine echocardiogram on all incoming freshmen, how could Journey Brown’s hypertrophic cardiomyopathy not identified until a Covid related echocardiogram screening as a junior? I am not aware that you can develop this between your freshman and junior year. I suppose they could have thought it was apical hypertrophic cardiomyopathy initially and allowed him to play and then it became more clear it was true hypertropic cardiomyopathy. Thoughts?

Edit-sounds like they do routine testing on incoming freshman at Penn State as they have lost a few players in recent years because of the screening. Thus, for some reason it was missed on the initial incoming freshman screening.